CV301 TRICOM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CV301 TRICOM, covering 2023-05-03 to 2023-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT) [Phase 1, Phase 2]